Form 4: Bausch + Lomb Executive Granted 35,046 RSUs

Bausch + Lomb's EVP of R&D and CMO, Yehia Hashad, was granted 35,046 restricted share units, increasing his beneficial ownership.

Summary

• Yehia Hashad, Executive Vice President of Research & Development and Chief Medical Officer (EVP of R&D and CMO) of Bausch & Lomb Corp (BLCO), was granted 35,046 restricted share units (RSUs).
• The grant occurred on February 25, 2026, under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan.
• These RSUs are scheduled to vest one-third on each of the first three anniversaries of the grant date, contingent upon Mr. Hashad's continued service.
• Following this transaction, Mr. Hashad's beneficial ownership of common shares increased to 198,906.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a routine executive compensation event that positively aligns management's long-term interests with shareholder value, reflecting standard corporate governance practices.

Positives

• The grant of restricted share units aligns the executive's long-term interests with those of shareholders, incentivizing sustained performance and value creation.
• Increased beneficial ownership by a key executive like Yehia Hashad demonstrates a commitment to the company's future and strategic objectives.

Negatives

• The future settlement of these restricted share units into common shares could result in minor dilution for existing shareholders.

Risks

• The vesting of the restricted share units is subject to the reporting person's continued service, meaning the executive risks forfeiture of unvested units if employment terminates before the scheduled vesting dates.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that the grant of restricted share units is a standard practice in executive compensation across various industries, including pharmaceuticals and medical devices, designed to incentivize long-term performance and align management interests with shareholder value creation.

Stakeholder Impact

• Shareholders: May experience minor dilution upon RSU vesting but benefit from incentivized executive performance.
• Executive (Yehia Hashad): Receives long-term incentive compensation tied to company performance and continued employment.

Next Steps

• Vesting of restricted share units will occur in three equal tranches on February 25, 2027, February 25, 2028, and February 25, 2029, subject to continued service.

Key Dates

Keywords

Bausch + Lomb, BLCO, Restricted Share Units, RSU Grant, Executive Compensation, Insider Transaction, Yehia Hashad, Omnibus Incentive Plan, Corporate Governance